European parliament adopts report on FP7

The European Parliament has adopted the report outlining the Seventh Framework Programme (FP7) by an overwhelming majority. This endorses the structure of FP7. The report now gives broad support to the European Commission's proposed work programme, which will have a budget of EUR 50,521 billion. The Parliament also adopted, by a large majority, the report on the proposed European Atomic Energy Community's seventh Framework Programme (EURATOM).

Although EUR 50,521 billion is lower than both the Commission and many MEPs wanted, it is substantially higher than the EUR 16 billion budget of the current Framework Programme. MEPs were happy with the nine thematic areas outlined by the Commission, but voted to split the 'security and space' theme into two separate headings. They also stipulated that two thirds of the Energy budget should go towards research into renewable energy activities, energy efficiency and savings, and made some other adjustments to the allocation of funds among the different parts of the programme.

The votes on amendments referring to stem cell research were extremely close. In the end, the MEPs voted by a majority of just 25 votes to follow the line suggested by the Parliament Committee on Industry, Research and Energy (ITRE), i.e. research on the use of both adult and embryonic human stem cells may be funded by FP7, subject to national laws and strict licensing rules. Italian MEP Marco Cappato, who is strongly in favour of stem cell research, described the vote as 'a success for a secular and tolerant Europe.' The result will be a disappointment to pro-life groups which have argued strongly against funding stem cell research.

The Parliament was enthusiastic about the creation of the European Research Council (ERC), but wanted to be sure it would enjoy real autonomy. They suggest it should be set up as an Executive Agency, before becoming an independent structure, after a brief transition phase. The Parliament asked the Commission to present a proposal to both the Parliament and Council, to "implement the ERC as a permanent, legally independent structure." An independent review of the ERC, will be held in 2008, when its structures and mechanisms may be modified.

"The programme is designed to respond to the competitiveness and employment needs of the EU," said Jerzy Buzek, the Polish MEP who drafted both the reports presented to the European Parliament. "It is my hope that the speed at which we have worked on the Seventh Framework Programme will be sustained. The European community of scientists and industry is looking forward to the successful start of the programme. All of us in the EU are waiting for the success of the Lisbon Strategy."

In a statement, the European Commission welcomed the vote, commenting that it remained largely in line with the original Commission proposal.

The document will now be debated by Member States, before a second reading in the Parliament later this year. The spokesperson for European research Commissioner, Janez Potocnik, welcomed the vote, saying it went very much in favour of the Commission's original proposal.

For further information, please visit: http://www.europarl.europa.eu/default.htm

Most Popular Now

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

New Research Shows Promise and Limitatio…

Published in JAMA Network Open, a collaborative team of researchers from the University of Minnesota Medical School, Stanford University, Beth Israel Deaconess Medical Center and the University of Virginia studied...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

Hampshire Emergency Departments Digitise…

Emergency departments in three hospitals across Hampshire Hospitals NHS Foundation Trust have deployed Alcidion's Miya Emergency, digitising paper processes, saving clinical teams time, automating tasks, and providing trust-wide visibility of...

MEDICA HEALTH IT FORUM: Success in Maste…

11 - 14 November 2024, Düsseldorf, Germany. How can innovations help to master the great challenges and demands with which healthcare is confronted across international borders? This central question will be...

A "Chemical ChatGPT" for New M…

Researchers from the University of Bonn have trained an AI process to predict potential active ingredients with special properties. Therefore, they derived a chemical language model - a kind of...

Siemens Healthineers co-leads EU Project…

Siemens Healthineers is joining forces with more than 20 industry and public partners, including seven leading stroke hospitals, to improve stroke management for patients all over Europe. With a total...

MEDICA and COMPAMED 2024: Shining a Ligh…

11 - 14 November 2024, Düsseldorf, Germany. Christian Grosser, Director Health & Medical Technologies, is looking forward to events getting under way: "From next Monday to Thursday, we will once again...

In 10 Seconds, an AI Model Detects Cance…

Researchers have developed an AI powered model that - in 10 seconds - can determine during surgery if any part of a cancerous brain tumor that could be removed remains...